Characterization of asthma exacerbations by Arg16Gly genotype in subjects with asthma receiving salmeterol alone or with fluticasone propionate

H. Nelson, E. Bleecker, J. Corren, S. Yancey, D. Reilly, A. Emmett, W. Anderson, H. Ortega (Denver, CO, Winston Salem, NC, Los Angeles, CA, Research Triangle Park, NC, United States Of America)

Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Session: Improving asthma and anti-allergic therapy
Session type: Thematic Poster Session
Number: 2003
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Nelson, E. Bleecker, J. Corren, S. Yancey, D. Reilly, A. Emmett, W. Anderson, H. Ortega (Denver, CO, Winston Salem, NC, Los Angeles, CA, Research Triangle Park, NC, United States Of America). Characterization of asthma exacerbations by Arg16Gly genotype in subjects with asthma receiving salmeterol alone or with fluticasone propionate. Eur Respir J 2008; 32: Suppl. 52, 2003

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment effectiveness and exacerbations during one year with seretide compared to fluticasone propionate and salmeterol in mild-to-moderate asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 176s
Year: 2001

Effect of discontinuation of inhaled fluticasone propionate on exacerbations in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 183s
Year: 2001

Survival in COPD patients after regular use of fluticasone propionate and salmeterol
Source: Eur Respir J 2003; 21: 559-560
Year: 2003


Budesonide and formoterol in a single inhaler quickly gains asthma control compared with fluticasone propionate in mild asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 48s
Year: 2001

Once-daily, high-dose inhaled fluticasone propionate and salmeterol in patients having moderate asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 125s
Year: 2004

Montelukast compared with fluticasone proprionate in children with persistent asthma
Source: ISSN=ISSN 1810-6838, ISBN=, page=267
Year: 2006

The effects of fluticasone propionate in asthmatic patients
Source: Eur Respir J 2004; 24: Suppl. 48, 125s
Year: 2004

Airway hyperresponsiveness and treatment effectiveness during a one year study of the combination of salmeterol and fluticasone propionate (FP) compared with FP and salmeterol alone in mild to moderate asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 386s
Year: 2002

Effects of Arg16Gly polymorphism in ADRB2 gene on responses to salmeterol or montelukast added to inhaled corticosteroids in Japanese asthmatic subjects
Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Year: 2012

Low-dose fluticasone is superior to montelukast in asthma patients
Source: Eur Respir J 2001; 18: Suppl. 33, 262s
Year: 2001

Aerosolized fluticasone propionate therapy in acute moderate exacerbations of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 45s
Year: 2002

Efficacy of high-dose inhaled fluticasone propionate in Indian patients having moderate asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002

Costs of avoiding exacerbations in patients with chronic obstructive pulmonary disease (COPD) treated with salmeterol/ fluticasone propionate combination (seretide) and salmeterol
Source: Eur Respir J 2004; 24: Suppl. 48, 291s
Year: 2004

The effects of treatment with fluticasone propionate alone and combination with salmeterol on asthma control and airway inflammation
Source: Eur Respir J 2003; 22: Suppl. 45, 287s
Year: 2003

Efficacy and safety of ciclesonide compared with fluticasone propionate or budesonide in adolescent patients with persistent asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 458s
Year: 2007

Efficacy and safety of ciclesonide compared with fluticasone propionate in patients with moderate to severe asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 206s
Year: 2006

Achievement of total control of asthma in clinical practice using the combination of inhaled salmeterol and fluticasone propionate
Source: Eur Respir J 2006; 28: Suppl. 50, 616s
Year: 2006

Budesonide and formoterol in a single inhaler controls exacerbations more effectively than a higher dose of inhaled corticosteroids alone, in mild-moderate persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 43s
Year: 2001

Comparison of formoterol and terbutaline for treatment of asthma exacerbations in children and adolescents
Source: Eur Respir J 2004; 24: Suppl. 48, 343s
Year: 2004

Effect of fluticasone and montelukast in school children with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 459s
Year: 2007